eXoZymes Inc. Common Stock EXOZ Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 1.3×-1.2× | 2.5×-2.0× | 4.5×-1.7× | 6.2×— | —— | |
| Quick ratio | 1.3×-1.2× | 2.5×-2.0× | 4.5×-1.7× | 6.2×— | —— | |
| Cash ratio | 0.9×-1.0× | 1.9×-2.2× | 4.1×-1.6× | 5.7×— | —— | |
| Leverage | ||||||
| Debt-to-equity | 0.8×+0.4× | 0.4×+0.1× | 0.3×— | —— | —— | |
| Debt-to-assets | 0.3×+0.1× | 0.2×0.0× | 0.2×0.0× | 0.1×— | —— | |
| Interest coverage | -36.1×-9.2× | -26.8×+11.8× | -38.6×-1.6× | -37×— | —— | |
| Per Share | ||||||
| Book value per share | $0.18-55.4% | $0.41-36.8% | $0.64-25.8% | $0.86-18.6% | $1.06-33.1% | |
| Valuation | ||||||
| Market capitalization | $76.8M-3.3% | —— | —— | —— | —— | |
| Enterprise value | $76.57M+3.5% | —— | —— | —— | —— | |
| Price / book | 51.5×+40.3× | —— | —— | —— | —— | |
| Free cash flow yield | -9%+2.3pp | —— | —— | —— | —— | |
| Earnings yield | -12.3%-2.8pp | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do eXoZymes Inc. Common Stock's ratios come from?
- Every ratio is computed from eXoZymes Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
